(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.28%) $78.33
(0.19%) $2.15
(0.52%) $2 320.50
(1.72%) $27.15
(-0.49%) $960.60
(0.02%) $0.929
(-0.10%) $10.86
(0.00%) $0.797
(0.00%) $91.45
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
0.00% ¥ 18.00
Live Chart Being Loaded With Signals
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 2.54M |
Średni wolumen | 2.47M |
Kapitalizacja rynkowa | 4.03B |
EPS | ¥0 ( 2024-02-08 ) |
Następna data zysków | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥0 ( N/A ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -3.13 |
ATR14 | ¥0.196 (1.15%) |
Wolumen Korelacja
OncoTherapy Science, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OncoTherapy Science, Inc. Korelacja - Waluta/Towar
OncoTherapy Science, Inc. Finanse
Annual | 2022 |
Przychody: | ¥1.13B |
Zysk brutto: | ¥41.69M (3.67 %) |
EPS: | ¥-5.81 |
FY | 2022 |
Przychody: | ¥1.13B |
Zysk brutto: | ¥41.69M (3.67 %) |
EPS: | ¥-5.81 |
FY | 2022 |
Przychody: | ¥1.15B |
Zysk brutto: | ¥113.91M (9.87 %) |
EPS: | ¥-13.72 |
FY | 2021 |
Przychody: | ¥332.48M |
Zysk brutto: | ¥19.54M (5.88 %) |
EPS: | ¥-8.86 |
Financial Reports:
No articles found.
OncoTherapy Science, Inc.
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej